These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18285668)

  • 1. Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan.
    Sato M; Saito R; Sato I; Tanabe N; Shobugawa Y; Sasaki A; Li D; Suzuki Y; Sato M; Sakai T; Oguma T; Tsukada H; Gejyo F; Suzuki H
    Tohoku J Exp Med; 2008 Feb; 214(2):113-20. PubMed ID: 18285668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of fever following influenza virus infection in children treated with oseltamivir.
    Suzuki E; Ichihara K
    J Med Virol; 2008 Jun; 80(6):1065-71. PubMed ID: 18428131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of four types of neuraminidase inhibitors approved in Japan for the treatment of influenza.
    Mawatari M; Saito R; Hibino A; Kondo H; Yagami R; Odagiri T; Tanabe I; Shobugawa Y;
    PLoS One; 2019; 14(11):e0224683. PubMed ID: 31697721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
    Sugaya N; Tamura D; Yamazaki M; Ichikawa M; Kawakami C; Kawaoka Y; Mitamura K
    Clin Infect Dis; 2008 Aug; 47(3):339-45. PubMed ID: 18582202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
    Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
    Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kanazawa H; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Nagai T; Horii S; Hirotsu N; Kashiwagi S
    J Infect; 2008 Jan; 56(1):51-7. PubMed ID: 17936910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.
    Toriumi Y; Kamei T; Murata K; Takahashi I; Suzuki N; Mazda O
    Forsch Komplementmed; 2012; 19(4):179-86. PubMed ID: 22964983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of four neuraminidase inhibitors (oseltamivir, zanamivir, laninamivir, and peramivir) for children with influenza A and B in the 2014-2015 to 2016-2017 influenza seasons in Japan.
    Ishiguro N; Koseki N; Kaiho M; Ariga T; Kikuta H; Oba K; Togashi T; Morita K; Inagawa A; Okamura A; Yamazaki S; Shida S; Konno M; Kawamura N; Ishizaka A; Takada K; Tsubakihara K; Nagano N; Shibata M; Furuyama H; Matsuzono Y; Koike A; Murashita M; Hatae Y; Arioka H; Yamanaka T; Watanabe T; Tabata Y; Kumita Y; Hazama K; Akutsu Y; Aoyagi H; Tobise C; Azuma K; Yasoshima K; Sawada Y; Uetsuji K; Tsuchida A; Tsuchiyama A; Yasuda K; Odagawa Y; Yoshioka M
    J Infect Chemother; 2018 Jun; 24(6):449-457. PubMed ID: 29487035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
    Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan.
    Kawai N; Ikematsu H; Iwaki N; Kawamura K; Kawashima T; Kashiwagi S
    J Infect Chemother; 2007 Oct; 13(5):314-9. PubMed ID: 17982720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
    Aver'ianov AV; Babkin AP; Bart BIa; Volchetskiĭ AL; Minina ES; Kozyrev OA; Kostinov MP; Petrov DV; Sel'kova EP; Putilovskiĭ MA; Nechaev VB; Epshteĭn OI; Andrianova EN
    Antibiot Khimioter; 2012; 57(7-8):23-30. PubMed ID: 23350191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of oseltamivir treatment against influenza type A and type B infection in children].
    Mitamura K; Sugaya N; Nirasawa M; Shinjoh M; Takeuchi Y
    Kansenshogaku Zasshi; 2002 Nov; 76(11):946-52. PubMed ID: 12508478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent changes in the trends of seasonal influenza outbreaks in the Nagano Prefectural area of Japan: an oseltamivir effect?
    Yasui K; Amano Y; Minami I; Nakamura S; Akazawa Y; Uchida N
    J Infect Chemother; 2007 Dec; 13(6):429-31. PubMed ID: 18095096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of pandemic influenza H1N1 virus in young patients after oseltamivir therapy in the 2009-2010 season: a comparison with seasonal H1N1 with or without H275Y mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Iwakuni O; Egashira K; Yamaji K; Kashiwagi S
    J Infect Chemother; 2012 Apr; 18(2):180-6. PubMed ID: 22193710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of oseltamivir in children with suspected influenza: a multicenter randomized open-label trial].
    He CH; Liu CY; Lin GY; Peng Q; Liao JY; Lin JH; Zhang T; Zheng XF; Lin CX; Wang SJ; Chen RS; Deng L; Chen YM
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):462-467. PubMed ID: 28592016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.